Intracerebral Hemorrhage - Life Sciences Discovery...

1
Ayala C et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 33:1197-1201, 2002 Blinc A et al. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993; 81:2636-43 Tuhrim S et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617-621 Vespa Pet al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocritcal Care. 2005;2:274-281 Morgenstern LB et al. Surgical treatment for intracerebral hemorrhage, Neurology, 1998;51:1359-1363 Intracerebral hemorrhage (ICH) occurs in over 100,000 Americans each year and has no effective treatment. It is fatal in 30% to 50% of all occurrences and the majority of survivors have significant motor and cognitive disability. The severity of brain injury is related to the volume of blood clot and the exposure time. ICH is easily and rapidly identified. It occurs in younger patients, and it initially produces a smaller injury to the cerebral tissues, suggesting that amelioration is possible with the right intervention that promotes effective blood clot removal. ICH is frequently complicated by intraventricular hemorrhage (IVH). IVH increases mortality to as high as 80%. IVH obstructs cerebrospinal fluid (CSF) flow and leads to hydrocephalus. Re-establishing CSF flow is considered a neurosurgical emergency requiring ventricular catheter placement. These catheters control ICP, but do not enhance blood removal. Research demonstrating the value of blood removal suggests that rapid and complete removal is desirable, but rarely achieved with current technology. It has been recently demonstrated that ultrasound markedly increases the rate of blood clot lysis produced by the thrombolytic substance recombinant tissue plasminogen activator (rt-PA) Current surgical care for ICH is open craniotomy, with a small, 4% benefit that remains controversial. Craniotomy is associated with poor patient stability, substantial brain tissue injury, and frequent rebleeding. In IVH a ventriculostomy is placed blindly into the contra lateral ventricle. This technique is complicated by inaccurate placement of the catheter, progression of bleeding and injury to normal brain tissue. In contrast, data from human and animal models demonstrate that minimally invasive surgery (MIS) techniques and thrombolytics can substantially reduce blood clot size and the area of brain tissue in direct contact with blood, resulting in better patient stability, substantially decreased tissue injury, and minimal bleeding or infection. The long-term goal of this research is to change the way ICH and IVH are treated, reducing brain injury with catheter based surgical and clinical management. This innovative approach combines local delivery of rt-PA with ultrasound enhancement to provide effective hematoma removal. Thirty five patients with spontaneous intracerebral hemorrhage were screened for inclusion into the study. A total of 9 patients were entered into the study and completed treatment. Treatment was conducted in the operating room and included placement of a burr hole, and navigation of the ultrasound and drainage catheter into the hemorrhage using a GPS-like system (STEALTH) for optimal catheter placement. Ultrasound was then delivered to the hemorrhage in addition to the thrombolytic drug tissue pasminogen activator rt-PA for 24 hours. Drainage was continued for a total of 48 hours in most patients. Figure 1 Figure 2 Figure 3 Figure 3 is a table illustrating the results of treatment in 9 patients treated for their hemorrhage using the SLEUTH protocol. There was one death within 30 days due to the severity of the hemorrhage, no catheter infections, and no bleeding episodes or other significant adverse events * Incomplete ultrasound treatment due to breakage of catheter Minimally invasive surgery using neuro-navigation techniques for catheter placement combined with ultrasound aided thrombolytic treatment and drainage appears to be well tolerated and safe. The procedure is very effective for blood clot removal and relief of mass effect in the brain following intracranial hemorrhage. This procedure may play a major role in the future treatment of intracranial hemorrhage. A larger multi-center trial for safety and efficacy with a redesigned catheter is warranted. The authors and participants would like to thank the Life Sciences Discovery Fund for the funding which made this study possible. We would also like to thank Swedish Hospital and Swedish Neuroscience Institute for their participation and collaboration, and EKOS corporation for their help and support Figure 2 illustrates (left) the initial hemorrhage, (center) catheter placement , and (right) the disappearance of blood clot within the cerebral ventricle within 24 hours after initiation of treatment Intracerebral Hemorrhage Pt # Sex Age Site Treated Initial Volume 24 hour Volume Reduction 1 M 55 IVH IVH 18 ICH 32 ml 78% 0% 2 M 61 ICH 99 ml 80% 3 F 82 ICH 27.7 ml 80% 4 M 68 IVH Died in hospital 5 F 83 ICH 40 80% 6 F 56 ICH 27 ml 40%* 7 M 59 ICH 40 ml 80% 8 M 38 ICH 70 ml 87% 9 M 70 IVH 40 ml 90%

Transcript of Intracerebral Hemorrhage - Life Sciences Discovery...

Page 1: Intracerebral Hemorrhage - Life Sciences Discovery Fundlsdfa.org/documents/Swedish_Newell_36x36.pdf · Ayala C et al. Sex differences in US mortality rates for stroke and stroke subtypes

AyalaCetal.SexdifferencesinUSmortalityratesforstrokeandstrokesubtypesbyrace/ethnicityandage,1995-1998.Stroke33:1197-1201,2002BlincAetal.Characterizationofultrasound-potentiatedfibrinolysisinvitro.Blood1993;81:2636-43TuhrimSetal.Volumeofventricularbloodisanimportantdeterminantofoutcomeinsupratentorialintracerebralhemorrhage.CritCareMed.1999;27:617-621VespaPetal.Framelessstereotacticaspirationandthrombolysisofdeepintracerebralhemorrhageisassociatedwithreductionofhemorrhagevolumeandneurologicalimprovement.NeurocritcalCare.2005;2:274-281MorgensternLBetal.Surgicaltreatmentforintracerebralhemorrhage,Neurology,1998;51:1359-1363

Intracerebralhemorrhage(ICH)occursinover100,000Americanseachyearandhasnoeffectivetreatment.Itisfatalin30%to50%ofalloccurrencesandthemajorityofsurvivorshavesignificantmotorandcognitivedisability.Theseverityofbraininjuryisrelatedtothevolumeofbloodclotandtheexposuretime.ICHiseasilyandrapidlyidentified.Itoccursinyoungerpatients,anditinitiallyproducesasmallerinjurytothecerebraltissues,suggestingthatameliorationis

possiblewiththerightinterventionthatpromoteseffectivebloodclotremoval.

ICHisfrequentlycomplicatedbyintraventricularhemorrhage(IVH).IVHincreasesmortalitytoashighas80%.IVHobstructscerebrospinalfluid(CSF)flowandleadstohydrocephalus.Re-establishingCSFflowisconsidereda

neurosurgicalemergencyrequiringventricularcatheterplacement.ThesecatheterscontrolICP,butdonotenhancebloodremoval.Researchdemonstratingthevalueofbloodremovalsuggeststhatrapidandcompleteremovalisdesirable,butrarelyachievedwithcurrenttechnology.Ithasbeenrecentlydemonstratedthatultrasoundmarkedlyincreasestherateof

bloodclotlysisproducedbythethrombolyticsubstancerecombinanttissueplasminogenactivator(rt-PA)

CurrentsurgicalcareforICHisopencraniotomy,withasmall,4%benefitthatremainscontroversial.Craniotomyisassociatedwithpoorpatientstability,substantialbraintissueinjury,andfrequentrebleeding.InIVHaventriculostomyisplacedblindlyintothecontralateralventricle.Thistechniqueiscomplicatedbyinaccurateplacementofthecatheter,

progressionofbleedingandinjurytonormalbraintissue.Incontrast,datafromhumanandanimalmodelsdemonstratethatminimallyinvasivesurgery(MIS)techniquesandthrombolyticscansubstantiallyreducebloodclotsizeandtheareaofbraintissueindirectcontactwithblood,resultinginbetterpatientstability,substantiallydecreasedtissueinjury,and

minimalbleedingorinfection.Thelong-termgoalofthisresearchistochangethewayICHandIVHaretreated,reducingbraininjurywithcatheterbasedsurgicalandclinicalmanagement.Thisinnovativeapproachcombineslocaldeliveryofrt-PAwithultrasoundenhancement

toprovideeffectivehematomaremoval.

Thirtyfivepatientswithspontaneousintracerebralhemorrhagewerescreenedforinclusionintothestudy.Atotalof9patientswereenteredintothestudyandcompletedtreatment.Treatmentwasconductedintheoperatingroomandincludedplacementofaburrhole,andnavigationoftheultrasoundanddrainagecatheterintothehemorrhageusingaGPS-likesystem(STEALTH)foroptimalcatheterplacement.Ultrasoundwasthendeliveredtothehemorrhageinadditiontothethrombolyticdrugtissuepasminogenactivator rt-PA for24hours.Drainagewascontinuedforatotalof48hoursinmostpatients.

Figure1

Figure2

Figure3

Figure3isatableillustratingtheresultsoftreatmentin9patientstreatedfortheirhemorrhageusingtheSLEUTHprotocol.Therewasonedeathwithin30daysduetotheseverityofthehemorrhage,nocatheterinfections,andnobleedingepisodesorothersignificantadverseevents

*Incompleteultrasoundtreatmentduetobreakageofcatheter

Minimallyinvasivesurgeryusingneuro-navigationtechniquesforcatheterplacementcombinedwithultrasoundaidedthrombolytictreatmentanddrainageappearstobewelltoleratedandsafe.Theprocedureisveryeffectiveforbloodclotremovalandreliefofmasseffectinthebrainfollowingintracranialhemorrhage.Thisproceduremayplayamajorroleinthefuturetreatmentofintracranialhemorrhage.Alargermulti-centertrialforsafetyandefficacywitharedesignedcatheteriswarranted.

TheauthorsandparticipantswouldliketothanktheLifeSciencesDiscoveryFundforthefundingwhichmadethisstudypossible.WewouldalsoliketothankSwedishHospitalandSwedishNeuroscienceInstitutefortheirparticipationandcollaboration,andEKOScorporationfortheirhelpandsupport

Figure2illustrates(left)theinitialhemorrhage,(center)catheterplacement,and(right)thedisappearanceofbloodclotwithinthecerebralventriclewithin24hoursafterinitiationoftreatment

Intracerebral Hemorrhage

Pt # Sex Age Site Treated

Initial Volume

24 hour Volume Reduction

1 M 55 IVH IVH 18 ICH 32 ml

78% 0%

2 M 61 ICH 99 ml 80%

3 F 82 ICH 27.7 ml 80%

4 M 68 IVH Died in hospital

5 F 83 ICH 40 80%

6 F 56 ICH 27 ml 40%*

7 M 59 ICH 40 ml 80%

8 M 38 ICH 70 ml 87%

9 M 70 IVH 40 ml 90%